This article was originally published by Specialty Pharmacy Continuum GRAPEVINE, Texas—Integrating pharmacy technicians into endocrinology clinics to help manage administrative burdens such as prior authorizations and medication refills for patients with type 2 diabetes can lead to faster access to

Shields demonstrates its unwavering commitment to specialty patient care through our latest patient outcomes in key disease states such as hepatitis C, HIV, rheumatoid arthritis (RA), and multiple sclerosis (MS).

This article was published in Managed Healthcare Executive on Sep 20, 2023. Learn how Shields Health Solutions is improving outcomes for people living with complex, chronic conditions, such as Multiple sclerosis (MS).

The poster highlights successful therapy responses in Rheumatoid arthritis patients within an integrated HSSP program, employing measures like RAPID3 and absenteeism data to improve disease management and quality of life. Future efforts include electronic data collection for enhanced response rates.

This poster highlights our collaboration with Proprium Pharmacy and how the HSSP model consistently improves HIV clinical outcomes, regardless of factors like age, gender, time on service, race/ethnicity, or insurance. Better viral load control relates to out-of-pocket expenses, emphasizing essential

This poster highlights the impact of an HSSP model on accessing Patient Assistance Program (PAP) funding for oral oncolytic drugs. Government-insured patients received PAP support more often with brand medications (92%) than generics (83%), underlining the importance of manufacturer support

This poster highlights how HSSP oncology patients had lower hospital utilization rates compared to a national network, indicating the potential for avoidable medical events. Implementing an integrated care model with monitoring can mitigate these events and reduce costs.

This poster spotlights our collaboration with NYULangone Health and highlights how the success of an ambulatory pharmacist-led program within an HSSP in efficiently handling mavacamten therapy and REMS program requirements for HCM patients. This replicable model can expand access to

This poster highlights the positive impact of introducing ACP services into a hematology/oncology clinic, leading to successful outcomes and substantial cost savings following HSSP integration. Challenges in cost estimation stemmed from diverse data sources, including oral oncology medications.

This poster spotlights our collaboration with NYULangone Health and highlights how the integration of ACP-let medication management services, specializing in diabetes care, into an integrated HSSP results in markedly improved outcomes for individuals with T2D and a reduction in associated